Skip to main content
Erschienen in: Rheumatology International 6/2013

01.06.2013 | Original Article

Death-related factors of systemic lupus erythematosus patients associated with the course of disease in Chinese populations: multicenter and retrospective study of 1,958 inpatients

verfasst von: Jiang Zhen, Sun Ling-yun, Zou Yao-hong, Wang Xiang-dang, Pan Jie-ping, Zhang Miao-jia, Tao Juan, Zhang Yu, Tan Kui-lin, Li Jing, Chen Zhi-wei, Ding Xiang, Qian Xian, Da Zhan-yun, Wang Mei-mei, Pan Wen-you

Erschienen in: Rheumatology International | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Despite the improved survival rate among systemic lupus erythematosus (SLE) patients, there are many factors associated with the mortality of SLE. In the current study, death-related factors of patients associated with course of disease were surveyed. Retrospective study was used. Mortalities among these three groups (group A, B and C, the course of disease was ≤5 years, 5–10 years and >10 years, respectively) were calculated and compared. Various factors related to mortality were analyzed. Male SLE patients died relatively more than female patients. The total mortality was 8.5 %. The mortalities were significant difference in group A, B and C which were 9.4, 4.8 and 8.9 %, respectively. The mortalities of group A and group C were significantly higher than that of group B, but there was no significant difference between mortalities of group A and group C. The most common death-related factor was infection, followed by involved disorders in renal, brain, multisystem, heart, etc. The mortalities resulted from neuropsychiatric systemic lupus erythematosus (NPSLE), pulmonary infection, involved digestive system and hematological system were significantly different between three groups. There was no difference between mortalities of group A and group C associated with pulmonary infection and NPSLE. Patients in group C died more than in group A from involved renal, heart, multisystem, etc, while group A had more patients than group C who died of pulmonary infection, involved hematological system. In conclusion, Male SLE patients have worse outcome than female patients. Infection and active SLE are not only contributors to the death of early stage patients, but also to that of later stage patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kasitanon N, Magder LS, Petri M (2006) Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 85:147–156CrossRef Kasitanon N, Magder LS, Petri M (2006) Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 85:147–156CrossRef
2.
Zurück zum Zitat Cervera R, Khamashta MA, Font J et al (2003) Morbility and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82:299–308CrossRef Cervera R, Khamashta MA, Font J et al (2003) Morbility and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82:299–308CrossRef
3.
Zurück zum Zitat Bernatsky S, Boivin JF, Joseph L et al (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54:2550–2557CrossRef Bernatsky S, Boivin JF, Joseph L et al (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54:2550–2557CrossRef
4.
Zurück zum Zitat Abu-Shakra M, Gladman DD, Urowitz MB (2004) Mortality studies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev 3:418–420CrossRef Abu-Shakra M, Gladman DD, Urowitz MB (2004) Mortality studies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev 3:418–420CrossRef
5.
Zurück zum Zitat Doria A, Laccarino L, Ghirardello A et al (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119:700–706CrossRef Doria A, Laccarino L, Ghirardello A et al (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119:700–706CrossRef
6.
Zurück zum Zitat Rubin LA, Urowitz MB, Gladman DD (1985) Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 55:87–89PubMed Rubin LA, Urowitz MB, Gladman DD (1985) Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 55:87–89PubMed
7.
Zurück zum Zitat Deng DQ, Xie H et al (2008) Causes of death for 43 patients of systemic lupus erythematosus. Chin J Rheumatol 12:285 Deng DQ, Xie H et al (2008) Causes of death for 43 patients of systemic lupus erythematosus. Chin J Rheumatol 12:285
8.
Zurück zum Zitat Fei YY, Zhang FC (2008) Mortality and causes of death of systemic lupus erythematosus in the past two decades. Chin J Rheumatol 12:187–191 Fei YY, Zhang FC (2008) Mortality and causes of death of systemic lupus erythematosus in the past two decades. Chin J Rheumatol 12:187–191
9.
Zurück zum Zitat Alamanos Y, Voulgari PV, Papassava M et al (2003) Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort. Rheumatology 42:1122–1123CrossRef Alamanos Y, Voulgari PV, Papassava M et al (2003) Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort. Rheumatology 42:1122–1123CrossRef
10.
Zurück zum Zitat Specker C, Becker A, Lakomek HJ et al (1994) Systemic lupus erythematosus in men—a different prognosis? Z Rheumatol 53:339–345PubMed Specker C, Becker A, Lakomek HJ et al (1994) Systemic lupus erythematosus in men—a different prognosis? Z Rheumatol 53:339–345PubMed
11.
Zurück zum Zitat Li H, Li X, Chu G et al (2000) A clinic analysis of 62 male patients with lupus nephritis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 22:395–397PubMed Li H, Li X, Chu G et al (2000) A clinic analysis of 62 male patients with lupus nephritis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 22:395–397PubMed
12.
Zurück zum Zitat Mayor AM, Vilá LM (2003) Gender differences in a cohort of Puerto Ricans with systemic lupus erythematosus. Cell Mol Biol (Noisy-le-grand) 49:1339–1344 Mayor AM, Vilá LM (2003) Gender differences in a cohort of Puerto Ricans with systemic lupus erythematosus. Cell Mol Biol (Noisy-le-grand) 49:1339–1344
13.
Zurück zum Zitat Kaufman LD, Gomez-Reino JJ, Heinicke MH et al (1989) Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature. Semin Arthritis Rheum 18:189–197CrossRef Kaufman LD, Gomez-Reino JJ, Heinicke MH et al (1989) Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature. Semin Arthritis Rheum 18:189–197CrossRef
14.
Zurück zum Zitat Feng X, Zou Y, Pan W et al (2011) Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China. J Rheumatol 38:1289–1295CrossRef Feng X, Zou Y, Pan W et al (2011) Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China. J Rheumatol 38:1289–1295CrossRef
15.
Zurück zum Zitat Rabbani MA, Habib HB, Islam M et al (2009) Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus 18:845–855CrossRef Rabbani MA, Habib HB, Islam M et al (2009) Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus 18:845–855CrossRef
16.
Zurück zum Zitat Fessler BJ (2002) Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 16:281–291CrossRef Fessler BJ (2002) Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 16:281–291CrossRef
17.
Zurück zum Zitat Abu-Shakra M, Urowitz MB, Gladman DD et al (1995) Mortality study in systemic lupus erythematosus. Results from a sinde center. 1. Causes of death. J Rheumatol 22:1259–1264PubMed Abu-Shakra M, Urowitz MB, Gladman DD et al (1995) Mortality study in systemic lupus erythematosus. Results from a sinde center. 1. Causes of death. J Rheumatol 22:1259–1264PubMed
18.
Zurück zum Zitat Wadee S, Tikly M, Hopley M (2007) Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology 46:1487–1491CrossRef Wadee S, Tikly M, Hopley M (2007) Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology 46:1487–1491CrossRef
Metadaten
Titel
Death-related factors of systemic lupus erythematosus patients associated with the course of disease in Chinese populations: multicenter and retrospective study of 1,958 inpatients
verfasst von
Jiang Zhen
Sun Ling-yun
Zou Yao-hong
Wang Xiang-dang
Pan Jie-ping
Zhang Miao-jia
Tao Juan
Zhang Yu
Tan Kui-lin
Li Jing
Chen Zhi-wei
Ding Xiang
Qian Xian
Da Zhan-yun
Wang Mei-mei
Pan Wen-you
Publikationsdatum
01.06.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 6/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2605-z

Weitere Artikel der Ausgabe 6/2013

Rheumatology International 6/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.